88 related articles for article (PubMed ID: 26518556)
1. Nuclear localization of translocation partners in differentiating B-cells.
Sklyar IV; Pichugin AM; Razin SV; Vassetzky ES; Iarovaia OV
Dokl Biochem Biophys; 2015; 464():312-4. PubMed ID: 26518556
[TBL] [Abstract][Full Text] [Related]
2. Distinct Patterns of Colocalization of the CCND1 and CMYC Genes With Their Potential Translocation Partner IGH at Successive Stages of B-Cell Differentiation.
Sklyar I; Iarovaia OV; Gavrilov AA; Pichugin A; Germini D; Tsfasman T; Caron G; Fest T; Lipinski M; Razin SV; Vassetzky YS
J Cell Biochem; 2016 Jul; 117(7):1506-10. PubMed ID: 26873538
[TBL] [Abstract][Full Text] [Related]
3. Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients.
Martin LD; Harizanova J; Zhu G; Righolt CH; Belch AR; Mai S; Pilarski LM
Genes Chromosomes Cancer; 2012 Aug; 51(8):727-42. PubMed ID: 22489023
[TBL] [Abstract][Full Text] [Related]
4. AID-targeting and hypermutation of non-immunoglobulin genes does not correlate with proximity to immunoglobulin genes in germinal center B cells.
Gramlich HS; Reisbig T; Schatz DG
PLoS One; 2012; 7(6):e39601. PubMed ID: 22768095
[TBL] [Abstract][Full Text] [Related]
5. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
Yan Y; Park SS; Janz S; Eckhardt LA
Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
[TBL] [Abstract][Full Text] [Related]
6. A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3' enhancers does not promote by itself B-cell malignancies.
Fiancette R; Amin R; Truffinet V; Vincent-Fabert C; Cogné N; Cogné M; Denizot Y
Leuk Res; 2010 Aug; 34(8):1043-51. PubMed ID: 20018375
[TBL] [Abstract][Full Text] [Related]
7. Nucleolar tethering mediates pairing between the IgH and Myc loci.
Strongin DE; Groudine M; Politz JC
Nucleus; 2014; 5(5):474-81. PubMed ID: 25482199
[TBL] [Abstract][Full Text] [Related]
8. Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma.
Martin LD; Harizanova J; Righolt CH; Zhu G; Mai S; Belch AR; Pilarski LM
Genes Chromosomes Cancer; 2013 Jun; 52(6):523-37. PubMed ID: 23460268
[TBL] [Abstract][Full Text] [Related]
9. Myc dynamically and preferentially relocates to a transcription factory occupied by Igh.
Osborne CS; Chakalova L; Mitchell JA; Horton A; Wood AL; Bolland DJ; Corcoran AE; Fraser P
PLoS Biol; 2007 Aug; 5(8):e192. PubMed ID: 17622196
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.
Nakagawa M; Tsuzuki S; Honma K; Taguchi O; Seto M
Haematologica; 2011 Sep; 96(9):1318-26. PubMed ID: 21606168
[TBL] [Abstract][Full Text] [Related]
11. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M
Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044
[TBL] [Abstract][Full Text] [Related]
12. Changes in replication, nuclear location, and expression of the Igh locus after fusion of a pre-B cell line with a T cell line.
Zhou J; Saleque S; Ermakova O; Sepulveda MA; Yang Q; Eckhardt LA; Schildkraut CL; Birshtein BK
J Immunol; 2005 Aug; 175(4):2317-20. PubMed ID: 16081801
[TBL] [Abstract][Full Text] [Related]
13. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
14. HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells.
Germini D; Tsfasman T; Klibi M; El-Amine R; Pichugin A; Iarovaia OV; Bilhou-Nabera C; Subra F; Bou Saada Y; Sukhanova A; Boutboul D; Raphaël M; Wiels J; Razin SV; Bury-Moné S; Oksenhendler E; Lipinski M; Vassetzky YS
Leukemia; 2017 Nov; 31(11):2515-2522. PubMed ID: 28360415
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.
Al-Kawaaz M; Mathew S; Liu Y; Gomez ML; Chaviano F; Knowles DM; Orazi A; Tam W
Am J Clin Pathol; 2015 Feb; 143(2):288-99. PubMed ID: 25596256
[TBL] [Abstract][Full Text] [Related]
16. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.
Silva S; Wiener F; Klein G; Janz S
Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas.
Hallermann C; Kaune KM; Gesk S; Martin-Subero JI; Gunawan B; Griesinger F; Vermeer MH; Santucci M; Pimpinelli N; Willemze R; Siebert R; Neumann C
J Invest Dermatol; 2004 Jul; 123(1):213-9. PubMed ID: 15191563
[TBL] [Abstract][Full Text] [Related]
18. Visualization of looping involving the immunoglobulin heavy-chain locus in developing B cells.
Sayegh CE; Jhunjhunwala S; Riblet R; Murre C
Genes Dev; 2005 Feb; 19(3):322-7. PubMed ID: 15687256
[TBL] [Abstract][Full Text] [Related]
19. The Ig heavy chain protein but not its message controls early B cell development.
Aslam MA; Alemdehy MF; Hao B; Krijger PHL; Pritchard CEJ; de Rink I; Muhaimin FI; Nurzijah I; van Baalen M; Kerkhoven RM; van den Berk PCM; Skok JA; Jacobs H
Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31343-31352. PubMed ID: 33229554
[TBL] [Abstract][Full Text] [Related]
20. Progressive activation of DNA replication initiation in large domains of the immunoglobulin heavy chain locus during B cell development.
Norio P; Kosiyatrakul S; Yang Q; Guan Z; Brown NM; Thomas S; Riblet R; Schildkraut CL
Mol Cell; 2005 Nov; 20(4):575-87. PubMed ID: 16307921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
